Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - August 2014


62nd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research

31 Aug 2014 - 04 Sep 2014 - University of Minho, Guimaraes, Portugal



Bookmark and Share


The Society for Medicinal Plant and Natural Product Research (GA) invites all scientists from academia and industry dealing with natural products, medicinal plants and phytotherapy, to this congress.

GA2014 is a forum for the presentation and discussion of the latest research in the fields of phytochemistry, analytics, pharmacology and clinical applications. The conference will provide a platform for networking between academia and industry.

GA2014 has been endorsed by the Association Francophone pour l'Enseignement et la Recherche en Pharmacognosie (AFERP). AFERP will have a special session.

The Congress will be held at the University of Minho, campus of Azurém, which is located in close vicinity to the medieval city centre of Guimarães, a UNESCO World Heritage Site. The historical city of Guimarães is located in Northern Portugal.

The dynamic and colorful Minho Region is famous for its landscape and vineyards where the unique “Vinho Verde” wine is produced. The University of Minho is a leading university in Portugal and offers an excellent setting for the Congress.

Plenary lectures by leading scientists, and several workshops will provide insights into topical aspects of medicinal plant and natural product research.

Apart from the scientific program, a stimulant and diverse social program will be proposed. This will include excursions to the Peneda-Gerês National Park and to the Northern seashore, with its wild beautiful coastal landscapes and unique biodiversity, and to the Douro Valley with its famous terraced vineyards. Guided visits to the cities of Porto and Guimarães, both classified as World Heritage Sites by UNESCO, are also planned.

Main scientific topics will include:

• Clinical phytomedicine
• Nanotechnology and drug delivery
• Natural compounds as leads
• Natural products from fungi and algae
• Nutritional phytochemicals
• Medicinal plants and bioeconomy
• Metabolomics
• Plant molecular farming



Further information
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!